Unconfigured Ad

Collapse

Discussion of any scientific study related to high content or next generation genomics. Whole genome association, metagenomics, digital gene expression, etc.

Forums Topics Posts Last Post
No forums found.
  •  
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by steven, 03-11-2010, 04:21 AM
10 responses
34,048 views
0 reactions
Last Post ECO
by ECO
 
Started by Newsbot!, 06-13-2012, 02:00 AM
0 responses
1,566 views
0 reactions
Last Post Newsbot!  
Started by Newsbot!, 06-13-2012, 02:00 AM
0 responses
1,915 views
0 reactions
Last Post Newsbot!  
Started by Michael.James.Clark, 06-29-2011, 08:35 PM
9 responses
7,730 views
0 reactions
Last Post bw.
by bw.
 
Started by Michael.James.Clark, 10-07-2011, 01:53 PM
5 responses
10,676 views
0 reactions
Last Post ymc
by ymc
 
Started by EBER, 05-03-2012, 05:24 AM
1 response
2,950 views
0 reactions
Last Post kopi-o
by kopi-o
 
Started by Newsbot!, 11-22-2011, 07:00 AM
0 responses
2,086 views
0 reactions
Last Post honey
by honey
 
Started by protist, 04-24-2012, 03:05 AM
6 responses
4,478 views
0 reactions
Last Post Heisman
by Heisman
 
Started by Newsbot!, 04-25-2012, 10:20 AM
2 responses
2,424 views
0 reactions
Last Post arvid
by arvid
 
Started by Newsbot!, 05-20-2011, 02:00 AM
11 responses
7,142 views
0 reactions
Last Post lshen
by lshen
 
Started by Newsbot!, 04-25-2012, 03:30 AM
0 responses
2,314 views
0 reactions
Last Post Newsbot!  
No topics found.
  • Time
Clear All
No photos found.
  • Time
Clear All

Webinars

Collapse

Recent Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    Yesterday, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 02:55 AM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Working...